These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 8622645
41. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. Pathrose P, Barmina O, Chang CY, McDonnell DP, Shevde NK, Pike JW. J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913 [Abstract] [Full Text] [Related]
42. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541 [Abstract] [Full Text] [Related]
43. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner. Whitfield GK, Selznick SH, Haussler CA, Hsieh JC, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR. Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271 [Abstract] [Full Text] [Related]
45. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. Yasmin R, Williams RM, Xu M, Noy N. J Biol Chem; 2005 Dec 02; 280(48):40152-60. PubMed ID: 16204233 [Abstract] [Full Text] [Related]
46. Retinoid X receptors in the kidney: their protein expression and functional significance. Sugawara A, Sanno N, Takahashi N, Osamura RY, Abe K. Endocrinology; 1997 Aug 02; 138(8):3175-80. PubMed ID: 9231765 [Abstract] [Full Text] [Related]
47. Additional protein factors play a role in the formation of VDR/RXR complexes on vitamin D response elements. Zierold C, DeLuca HF. J Cell Biochem; 1998 Dec 15; 71(4):515-23. PubMed ID: 9827697 [Abstract] [Full Text] [Related]
48. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Quack M, Carlberg C. Mol Pharmacol; 1999 Jun 15; 55(6):1077-87. PubMed ID: 10347251 [Abstract] [Full Text] [Related]
49. Calreticulin inhibits vitamin D3 signal transduction. Wheeler DG, Horsford J, Michalak M, White JH, Hendy GN. Nucleic Acids Res; 1995 Aug 25; 23(16):3268-74. PubMed ID: 7667104 [Abstract] [Full Text] [Related]
50. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Jeyakumar M, Tanen MR, Bagchi MK. Mol Endocrinol; 1997 Jun 25; 11(6):755-67. PubMed ID: 9171239 [Abstract] [Full Text] [Related]
51. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B, DeLuca HF. J Cell Biochem; 1999 Aug 01; 74(2):220-8. PubMed ID: 10404392 [Abstract] [Full Text] [Related]
52. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system. Zhao XY, Eccleshall TR, Krishnan AV, Gross C, Feldman D. Mol Endocrinol; 1997 Mar 01; 11(3):366-78. PubMed ID: 9058382 [Abstract] [Full Text] [Related]
53. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression. Jiménez-Lara AM, Aranda A. Endocrinology; 1999 Jun 01; 140(6):2898-907. PubMed ID: 10342883 [Abstract] [Full Text] [Related]
54. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Mol Pharmacol; 2001 Dec 01; 60(6):1399-406. PubMed ID: 11723248 [Abstract] [Full Text] [Related]
55. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. Solomon C, Sebag M, White JH, Rhim J, Kremer R. J Biol Chem; 1998 Jul 10; 273(28):17573-8. PubMed ID: 9651351 [Abstract] [Full Text] [Related]
56. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Tagami T, Lutz WH, Kumar R, Jameson JL. Biochem Biophys Res Commun; 1998 Dec 18; 253(2):358-63. PubMed ID: 9878542 [Abstract] [Full Text] [Related]
57. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Alroy I, Towers TL, Freedman LP. Mol Cell Biol; 1995 Oct 18; 15(10):5789-99. PubMed ID: 7565732 [Abstract] [Full Text] [Related]
58. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element. Hsieh JC, Whitfield GK, Jurutka PW, Haussler CA, Thatcher ML, Thompson PD, Dang HT, Galligan MA, Oza AK, Haussler MR. Endocrinology; 2003 Nov 18; 144(11):5065-80. PubMed ID: 12960019 [Abstract] [Full Text] [Related]
59. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor. Sánchez-Martínez R, Castillo AI, Steinmeyer A, Aranda A. EMBO Rep; 2006 Oct 18; 7(10):1030-4. PubMed ID: 16936639 [Abstract] [Full Text] [Related]